Cleared Traditional

K860688 - MONOJECT PHARMACY TRAY

K860688 is an FDA 510(k) clearance for MONOJECT PHARMACY TRAY, manufactured by Sherwood Medical Co.. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 527-day FDA review.

K860688 · Sherwood Medical Co. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1987
Decision
527d
Days
Class 2
Risk

K860688 is an FDA 510(k) clearance for the MONOJECT PHARMACY TRAY. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Sherwood Medical Co. (St. Louis, US). The FDA issued a Cleared decision on August 6, 1987 after a review of 527 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Sherwood Medical Co. devices

FDA 510(k) Submission Details - K860688

510(k) Number K860688 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 25, 1986
Decision Date August 06, 1987
Days to Decision 527 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
398d slower than avg
Panel avg: 129d · This submission: 527d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 484
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K860688.
JMS NEEDLES AND JMS SYRINGES
K871965 · Jms Co., Ltd. · Sep 1987
SAFETY SYRINGE
K872820 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Sep 1987
LOOK SPRING-ASSIST SYRINGES
K872944 · Look, Inc. · Sep 1987
SURGITEK PHYSICIAN DISPEN. PATIENT SELF-INJECT KIT
K870518 · Surgitek · Apr 1987
ACCUPEN(R)
K870078 · Ulster Scientific, Inc. · Mar 1987
REFILLABLE SYRINGE
K864407 · Med Fusion Systems, Inc. · Jan 1987